$62.10
-1.64 (-2.57%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-32.20%
1Y
+44.18%
YTD
-30.12%
Open$64.46
Previous Close$63.74
Day High$65.22
Day Low$61.38
52W High$118.84
52W Low$29.95
Volume—
Avg Volume665.0K
Market Cap2.74B
P/E Ratio—
EPS$-10.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$97.75
Below
SMA 200
$64.49
Below
RSI (14)
50.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
14 analysts
Price Target
-45.9% upside
Current
$62.10
$62.10
Target
$33.59
$33.59
$28.45
$33.59 avg
$56.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 171.85M | 124.20M | 2.02B |
| Net Income | -476,824,869 | -310,141,202 | 154.03M |
| Profit Margin | -277.5% | -263.6% | 7.6% |
| EBITDA | -500,085,666 | -343,341,318 | 214.07M |
| Free Cash Flow | — | — | 137.52M |
| Rev Growth | +38.4% | +38.4% | +15.5% |
| Debt/Equity | — | — | 0.96 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |